Epstein Secrets

ore; and the limited number of programs/productive activities currently available (with correspondingly far fewer points allocated by the tool)? 3. Developmental Sample Additional information is needed regarding the developmental sample. • Additional information is needed regarding the attributes of the developmen

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00100213 EXHIBIT B EFTA00100214

ore; and the limited number of programs/productive activities currently available (with correspondingly far fewer points allocated by the tool)? 3. Developmental Sample Additional information is needed regarding the developmental sample. • Additional information is needed regarding the attributes of the developmen

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00064950 EXHIBIT B EFTA00064951

ore; and the limited number of programs/productive activities currently available (with correspondingly far fewer points allocated by the tool)? 3. Developmental Sample Additional information is needed regarding the developmental sample. • Additional information is needed regarding the attributes of the developmen

stice, Bureau of Prisons, Drug Abuse Treatment Program, 81 Fed. Reg. 24484, 24488 (Apr. 26, 2016) ("over 5,000 inmates waiting to enter treatment"); Colson Task Force, at 36 Cat the end of FY 2014, more than 12,300 people systemwide were awaiting drug abuse treatment'). 20 EFTA00094068 EXHIBIT B EFTA00094069